Oxybutynin Chloride Extended Release

Warning

Oxybutynin Chloride Extended Release is contraindicated in patients with urinary retention, gastric retention, and uncontrolled narrow-angle glaucoma

Contraindications

• Urinary retention
• Gastric retention
• Uncontrolled narrow-angle glaucoma
• Known hypersensitivity to the drug substance or other components of the product

Adverse Reactions

• Dry mouth
• Constipation
• Diarrhea
• Headache
• Somnolence
• Dizziness

General Guidance

Dosage may be adjusted in 5-mg increments to achieve a balance of efficacy and tolerability

Pregnancy

• Oxybutynin Chloride Extended Release should be used during pregnancy only if the potential benefit to the patient outweighs the risk to the patient and fetus

Nursing Mothers

• Caution should be exercised when Oxybutynin Chloride Extended Release is administered to a nursing woman

Pediatric Use

• Oxybutynin Chloride Extended Release is not recommended in pediatric patients who cannot swallow the tablet whole without chewing, dividing, or crushing, or in children under the age of 6

Geriatric Use

• The rate and severity of anticholinergic effects reported by patients less than 65 years old and those 65 years and older were similar